SCV
ALMR

Sands Capital Ventures’s Alamar Biosciences ALMR Stock Holding History

Sands Capital Ventures’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115M Buy
+4,230,926
New +$95.7M 18.68% 1

Other funds holding ALMR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sands Capital Ventures's ALMR Position: Q2 2026 in Review

Sands Capital Ventures opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 4,230,926 shares worth $115M. The stake represents 18.68% of the portfolio and ranks #1 among its holdings.

40 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • Sands Capital Ventures held 4,230,926 shares of Alamar Biosciences worth $115M as of Q2 2026.
  • Alamar Biosciences was a new Sands Capital Ventures position in Q2 2026.
  • Alamar Biosciences made up 18.68% of Sands Capital Ventures's portfolio in Q2 2026, its #1 holding.
  • 40 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Sands Capital Ventures's 13F filing for Q2 2026, filed 13 Aug 2026.